Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial
- Resource Type
- Academic Journal
- Authors
- Sclafani, Francesco; Kim, Tae Y.; Cunningham, David; Kim, Tae W.; Tabernero, Josep; Schmoll, Hans J.; Roh, Jae K.; Kim, Sun Y.; Park, Young S.; Guren, Tormod K.; Hawkes, Eliza; Clarke, Stephen J.; Ferry, David; Frodin, Jan‐Erik; Ayers, Mark; Nebozhyn, Michael; Peckitt, Clare; Loboda, Andrey; Watkins, David J.
- Source
- International Journal of Cancer. Jan 15, 2017 140(2):431-439
- Subject
- Language
- English
- ISSN
- 0020-7136